126
Participants
Start Date
May 31, 2004
Primary Completion Date
April 30, 2008
Study Completion Date
April 30, 2008
Mycophenolate mofeteil (MMF)
Daclizumab (DZB)
Placebo control for Mycophenolate mofeteil (MMF)
Placebo pills taken orally
Placebo control for Daclizumab (DZB)
saline intravenous infusions
Columbia University, New York
University of Florida, Gainesville
Indiana University, Indianapolis
University of Minnesota, Minneapolis
Barbara Davis Center for Childhood Diabetes, University of Colorado, Denver
Childrens Hospital Los Angeles, Los Angeles
University of California-San Francisco, San Francisco
Benaroya Research Institute, Seattle
Stanford University, Stanford
Joslin Diabetes Center, Boston
Hospital for Sick Children, Toronto
Collaborators (1)
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NIH
Juvenile Diabetes Research Foundation
OTHER
National Center for Research Resources (NCRR)
NIH
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH